{"filing":{"accession_number":"0001628280-26-044492","cik":"0000016058","ticker":"CACI","company_name":"CACI INTERNATIONAL INC /DE/","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"caci-20260622.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/16058/000162828026044492/caci-20260622.htm"},"events":[{"id":12628,"run_id":11202,"accession_number":"0001628280-26-044492","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Dr. David Young as Chief Operating Officer of CACI International, reporting to the CEO. While the disclosure includes compensatory details (sign-on bonus of $500,000 and $2,000,000 in restricted stock units), the principal action is the appointment of a senior executive to a C-suite role. This is a material executive appointment that would affect investor assessment of the company's leadership and operational direction.","company_name":"CACI INTERNATIONAL INC /DE/","ticker":"CACI","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9534,"accession_number":"0001628280-26-044492","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. David Young as Chief Operating Officer of CACI International, reporting to the CEO. While the disclosure includes compensatory details (sign-on bonus of $500,000 and $2,000,000 in restricted stock units), the principal action is the appointment of a senior executive to a C-suite role. This is a material executive appointment that would affect investor assessment of the company's leadership and operational direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T15:28:30.184410+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9534,"accession_number":"0001628280-26-044492","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Dr. David Young as Chief Operating Officer of CACI International, reporting to the CEO. While the disclosure includes compensatory details (sign-on bonus of $500,000 and $2,000,000 in restricted stock units), the principal action is the appointment of a senior executive to a C-suite role. This is a material executive appointment that would affect investor assessment of the company's leadership and operational direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T15:28:30.184410+00:00","company_name":"CACI INTERNATIONAL INC /DE/","ticker":"CACI","filing_date":"2026-06-22"}]}